Stephen E. Weis - Concepedia

Author

Stephen E. Weis

Also Known As

M. Chow, S E Weis, S Weis, S. E. Weis, S. Weis, S.E. Weis, STEPHEN E. WEIS, STEPHEN E. WEIS, Steffen Weis, Stephen E Weis

129

Publications

14K

Citations

H-Index

Concepts

All Affiliations

University of North Texas University of North Texas Health Science Center Tarrant County College The University of Texas Health Science Center at Tyler Centers for Disease Control and Prevention

About

Stephen E. Weis is an author at University of North Texas specializing in medicine, tuberculosis, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.5K
2	Public Health	9	9	697
3	Arts	1	1	34
4	Education	1	1	34
5	Health Sciences	1	1	32

Stephen E. Weis

Publications

13.5K

Citations

H-Index

Page 1

	Year	Citations
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels John R. Downs, Michael Clearfield, Stephen E. Weis, JAMA	1998	5.3K
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events Paul M. Ridker, Nader Rifai, Michael Clearfield, New England Journal of Medicine	2001	1.6K
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection Timothy R. Sterling, Margarita E. Villarino, Andrey Borisov, New England Journal of Medicine	2011	946
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis Stephen E. Weis, Philip C. Slocum, Francis X. Blais, New England Journal of Medicine	1994	595
Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Antonio M. Gotto, Edwin J. Whitney, Evan A. Stein, Circulation	2000	566
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial Debra Benator, Mondira Bhattacharya, Lorna Bozeman, The Lancet Pulmonary TuberculosisTreatment And PreventionMedicineRandomised Clinical TrialWeek Versus Rifampicin	2002	408
Pulmonary Impairment After Tuberculosis Jotam G. Pasipanodya, Thaddeus L. Miller, Mauricio Vecino, CHEST Journal Pulmonary TuberculosisPulmonary CarePulmonary PathologyTuberculosis PreventionPulmonary Impairment	2007	239
Treatment for Preventing Tuberculosis in Children and Adolescents Margarita E. Villarino, Nigel Scott, Stephen E. Weis, JAMA Pediatrics	2015	218
Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and Rifapentine Marc Weiner, William J. Burman, Andrew Vernon, American Journal of Respiratory and Critical Care Medicine	2003	192
NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen Ramakrishna Vankayalapati, Peter Klucar, Benjamin Wizel, The Journal of Immunology	2004	172

Page 1